Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Antti Kiviaho"'
Autor:
Maria Koivisto, Tuomas A. Tolvanen, Tarja Toimela, Ilkka Miinalainen, Antti Kiviaho, Juha Kesseli, Matti Nykter, Lauri Eklund, Tuula Heinonen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC) are widely used in in vitro biomedical research and testing. However, fully matured, adult cardiomyocyte characteristics have not been achieved. To improve the maturity
Externí odkaz:
https://doaj.org/article/e91a2ccd543946a4a1e74761627a9c6c
Autor:
Antti Kiviaho, Heini M. Kallio, Sini K. Eerola, Elisa M. Vuorinen, Tomi Häkkinen, Sinja Taavitsainen, Ebrahim Afyounian, Teemu Tolonen, Juha Kesseli, Alfonso Urbanucci, Kirsi J. Rautajoki, Teuvo L. Tammela, Tapio Visakorpi, Matti Nykter
Publikováno v:
Cancer Research. 83:5644-5644
Background: Prostate cancer (PCa) is the second most common cancer in men. Despite its high prevalence, many patients carry an indolent form of the disease and are thus suspect to overtreatment. Conversely, some cases treated with androgen deprivatio
Autor:
Sinja Taavitsainen, Nikolai Engedal, Shaolong Cao, Florian Handle, Andrew Erickson, Stefan Prekovic, Daniel Wetterskog, Teemu Tolonen, Elisa M. Vuorinen, Antti Kiviaho, Reetta Nätkin, Tomi Häkkinen, Wout Devlies, Sallamari Henttinen, Roosa Kaarijärvi, Mari Lahnalampi, Heidi Kaljunen, Karolina Nowakowska, Heimo Syvälä, Merja Bläuer, Paolo Cremaschi, Frank Claessens, Tapio Visakorpi, Teuvo L. Tammela, Teemu Murtola, Kirsi J. Granberg, Alastair D. Lamb, Kirsi Ketola, Ian G. Mills, Gerhardt Attard, Wenyi Wang, Matti Nykter, Alfonso Urbanucci
Publikováno v:
Cancer Research. 82:401-401
Resistance to androgen receptor-targeted therapy due to tumor heterogeneity and clonal evolution is a key challenge for improving prostate cancer outcomes. Despite this, the transcriptomic and chromatin accessibility changes contributing to the emerg
Autor:
Sallamari Henttinen, Andrew Erickson, Roosa Kaarijärvi, Heidi Kaljunen, Tapio Visakorpi, Merja Bläuer, Alfonso Urbanucci, Mari Lahnalampi, Elisa M. Vuorinen, Paolo Cremaschi, Gerhardt Attard, Stefan Prekovic, Wout Devlies, Teuvo L.J. Tammela, Tomi Häkkinen, Karolina Nowakowska, Alastair D. Lamb, Sinja Taavitsainen, Shaolong Cao, Florian Handle, Antti Kiviaho, Teemu Tolonen, Kirsi Ketola, Heimo Syvälä, Daniel Wetterskog, Wenyi Wang, Kirsi J. Granberg, Ian G. Mills, Nikolai Engedal, Reetta Nätkin, Matti Nykter, Frank Claessens, Teemu J. Murtola
Prostate cancer is heterogeneous and patients would benefit from methods that stratify those who are likely to respond to systemic therapy. We employed single-cell assays for transposase-accessible chromatin (ATAC) and RNA sequencing in models of ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b12c9acb9aa5d20e72188dbcfe28bfb6
https://doi.org/10.21203/rs.3.rs-384422/v1
https://doi.org/10.21203/rs.3.rs-384422/v1